MASI - マシモ (Masimo Corporation) マシモ

 MASIのチャート


 MASIの企業情報

symbol MASI
会社名 Masimo Corp. (マシモ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 マシモ(Masimo Corporation) は医療技術企業であり、非侵襲患者モニタリング製品を開発・製造・販売する。同社の事業はマシモ信号抽出技術(SET)パルスオキシメトリーと知られる測定スルーモーションおよび低灌流パルスオキシメトリーモニタリングである。製品には光学特性、光学臓器酸素濃度測定、電気、脳機能モニタリング、音響呼吸モニタリング、呼気モニタリングなどの血液成分の非侵襲的モニタリングが含まれる。同社はまたRoot患者のモニタリングおよび接続プラットフォーム、Radical-7ベッドサイドとポータブル患者モニタ、Radius-7ウェアラブル無線患者モニタを開発する。同社はPatient SafetyNetリモート患者監視監視システムを提供する。これにより、患者はパーソナルコンピュータベースのモニタまたはポケベル、ボイスオーバーインターネットプロトコル(IP)電話、スマートフォンを通じてケア提供者によって監視される。   マシモは、米国の医療技術企業。非侵襲的患者監視製品を開発、製造、売買に従事する。患者監視ソリュ―ションは、一般的にはモニタ―や回路基板とセンサ―に組み込まれる。主にに直接パ―トナ―代理店もしくは元の機器メ―カ―を通じて、病院、救急医療サ―ビス・プロバイダ―、医師、獣医師、介護施設や消費者に同社製品を販売する。   
本社所在地 52 Discovery Irvine CA 92618 USA
代表者氏名 Joseph E. Kiani ジョセフ・E・キアニ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 949-297-7000
設立年月日 32629
市場名 NASDAQ National Market System
ipoyear 2007年
従業員数 4600人
url www.masimo.com
nasdaq_url https://www.nasdaq.com/symbol/masi
adr_tso
EBITDA EBITDA(百万ドル) 233.99600
終値(lastsale) 119.46
時価総額(marketcap) 6232234889.76
時価総額 時価総額(百万ドル) 650.162
売上高 売上高(百万ドル) 843.44700
企業価値(EV) 企業価値(EV)(百万ドル) 5620.515
当期純利益 当期純利益(百万ドル) 207.08600
決算概要 決算概要 BRIEF: For the 26 weeks ended 30 June 2018 Masimo Corporation revenues increased 9% to $424.6M. Net income decreased 7% to $89.5M. Revenues reflect United States segment increase of 10% to $281.2M Europe Middle East and Africa segment increase of 22% to $78.4M. Net income was offset by Selling general and administrative increase of 7% to $142.6M (expense) Research and development increase of 23% to $37.7M (expense).

 MASIのテクニカル分析


 MASIのニュース

   Masi Agricola, Red Circle Investments (Renzo Rosso) sale al 7,5%  2021/04/09 13:27:51 Investing.com Italy
https://it.investing.com/news/stock-market-news/masi-agricola-red-circle-investments-renzo-rosso-sale-al-75-1992402
   Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry - Stocks News Feed  2021/03/22 07:00:00 Stocks News Feed
NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo SET® pulse oximetry.1 The authors concluded that pulse oximetry… Read More »Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry
   Masimo Monitoring Solutions Promote Newborn and Maternal Safety  2021/03/08 05:00:00 Business Wire
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety, including SET® pulse oximetry.
   Masimo Announces CE Marking of the Rad-G™ with Temperature  2021/03/02 07:00:00 Business Wire
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo Rad-G™ with Temperature, a rugged handheld device with SET® pulse oximetry, respiration rate, and temperature measurement, received CE marking.
   may delivered a positive earnings surprise NASDAQ:SBAC NASDAQ:MASI NYSE:NBR NYSE:VVNT and #Covid-19 (#Coronavirus) impact  2021/02/26 02:14:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
   Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry - Stocks News Feed  2021/03/22 07:00:00 Stocks News Feed
NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo SET® pulse oximetry.1 The authors concluded that pulse oximetry… Read More »Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry
   Masimo Monitoring Solutions Promote Newborn and Maternal Safety  2021/03/08 05:00:00 Business Wire
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety, including SET® pulse oximetry.
   Masimo Announces CE Marking of the Rad-G™ with Temperature  2021/03/02 07:00:00 Business Wire
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo Rad-G™ with Temperature, a rugged handheld device with SET® pulse oximetry, respiration rate, and temperature measurement, received CE marking.
   may delivered a positive earnings surprise NASDAQ:SBAC NASDAQ:MASI NYSE:NBR NYSE:VVNT and #Covid-19 (#Coronavirus) impact  2021/02/26 02:14:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
   Masimo to Present in Raymond James 42nd Annual Institutional Investors Conference  2021/02/24 14:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Raymond James 42nd Annual Institutional Investors Conference on Wednesday, March 3, 2021 at 3:50 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a global medical technology company that develops
   Anesthesia And Respiratory Devices Market Report - Business Opportunities, Growth, Insights, Emerging Trends | Teleflex Incorporated, SunMed, Smiths Group Plc., ResMed Inc., Medtronic Plc., Masimo Corporation, Koninklijke Philips N.V., Invacare Corporatio  2020/12/18 04:19:40 OpenPR
The report titled ‘Global Anesthesia And Respiratory Devices Market Report,’ published by Verified Market Research, points towards the core features of the market under investigation. This report encircles the different market scenarios, ranging from current situation to the market conditions
   Insider Selling: Masimo Co. (NASDAQ:MASI) CEO Sells $15,150,230.28 in Stock  2020/12/13 09:04:44 Watchlist News
Masimo Co. (NASDAQ:MASI) CEO Joe E. Kiani sold 55,971 shares of the firm’s stock in a transaction dated Tuesday, December 8th. The stock was sold at an average price of $270.68, for a total value of $15,150,230.28. Following the completion of the transaction, the chief executive officer now owns 215,212 shares in the company, valued […]
   New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient Blood Management, with Reduced ICU Stays and Postoperative Transfusion - Stocks News Feed  2020/12/10 07:00:00 Stocks News Feed
NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Saraçoğlu and colleagues at Marmara University in Istanbul, Turkey investigated the efficacy of Masimo noninvasive and continuous hemoglobin monitoring, SpHb®, as part of the transfusion management of pediatric patients undergoing major surgery.1 The researchers found… Read More »New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient Blood Management, with Reduced ICU Stays and Postoperative Transfusion
   Global Pulse Oximeters Market Size, Share & Trends Analysis 2020-2027 by Type (Fingertip, Handheld) & End Use (Hospitals & Healthcare Facilities, Homecare)  2020/12/07 21:30:00 Benzinga
DUBLIN , Dec. 7, 2020 /PRNewswire/ -- The "Pulse Oximeters Market Size, Share & Trends Analysis Report by Type (Fingertip, Handheld), by End Use (Hospitals & Healthcare Facilities, Homecare), by Region ( North America , Europe , APAC, LATAM, MEA), and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The global pulse oximeters market size is expected to reach USD 3.2 billion by 2027, expanding at a CAGR of 6.4% Technological advancement in design and development of pulse oximeter is expected to boost market growth during the forecast period. Market players are introducing devices that are more compact, portable, ease to use, accurate, and efficient. For instance, in May 2019 , Masimo received FDA clearance for its first tetherless SET pulse oximeter, Radius PPG. Oxygen saturation monitors are conventionally used in pre and postsurgical settings. They are used during surgeries when patients are anesthetized. Increase in number of surgeries being performed and focus on patient safety are among the key factors responsible for increased use of the medical device during most procedures.
   Masimo’s COVID-19 Response Efforts Highlighted at California Life Sciences Association’s Pantheon 2020  2020/12/07 14:20:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo was featured at CLSA's Pantheon 2020 conference for its efforts to help clinicians and hospitals combat COVID-19.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 マシモ MASI Masimo Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)